Literature DB >> 11309200

Phosphorylation of p190 on Tyr1105 by c-Src is necessary but not sufficient for EGF-induced actin disassembly in C3H10T1/2 fibroblasts.

M D Haskell1, A L Nickles, J M Agati, L Su, B D Dukes, S J Parsons.   

Abstract

p190 RhoGAP is a tyrosine phosphorylated protein that contains an N-terminal GTP binding domain, a middle domain (MD) that mediates interaction with p120 RasGAP and a C-terminal GTPase-activating protein (GAP) domain that is specific for the &Rgr; family of small GTPases. Evidence is accumulating to suggest that p190 participates in actin cytoskeleton rearrangements that occur following transformation by v-Src or stimulation by growth factors, and that tyrosine phosphorylation of p190 by Src influences these processes. The current study was performed to establish whether p190RhoGAP directly participates in epidermal growth factor-induced actin stress fiber disassembly and how c-Src is involved in this process. Our results support a model in which the p190 MD negatively regulates the activity of the GAP domain and that c-Src phosphorylation of Y1105 is necessary, but insufficient on its own, for actin stress fiber disassembly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309200     DOI: 10.1242/jcs.114.9.1699

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  26 in total

1.  Mitotic down-regulation of p190RhoGAP is required for the successful completion of cytokinesis.

Authors:  Sergio A Sánchez Manchinelly; Joyce Agati Miller; Ling Su; Tsuyoshi Miyake; Lisa Palmer; Masahito Mikawa; Sarah J Parsons
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 2.  Central role of paxillin phosphorylation in regulation of LFA-1 integrins activity and lymphocyte migration.

Authors:  Larisa Y Romanova; J Frederic Mushinski
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

3.  Rho/RacGAPs: embarras de richesse?

Authors:  Roland Csépányi-Kömi; Magdolna Lévay; Erzsébet Ligeti
Journal:  Small GTPases       Date:  2012-07-01

4.  Localized RhoA activation as a requirement for the induction of membrane ruffling.

Authors:  Kazuo Kurokawa; Michiyuki Matsuda
Journal:  Mol Biol Cell       Date:  2005-06-29       Impact factor: 4.138

5.  The human papillomavirus E7 proteins associate with p190RhoGAP and alter its function.

Authors:  Biljana Todorovic; Anthony C Nichols; Jennifer M Chitilian; Michael P Myers; Trevor G Shepherd; Sarah J Parsons; John W Barrett; Lawrence Banks; Joe S Mymryk
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

6.  p190RhoGAP and Rap-dependent RhoGAP (ARAP3) inactivate RhoA in response to nerve growth factor leading to neurite outgrowth from PC12 cells.

Authors:  Chan Young Jeon; Hee Jun Kim; Jae Yong Lee; Jae Bong Kim; Sung Chan Kim; Jae Bong Park
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

7.  Extracellular signal-regulated kinase promotes Rho-dependent focal adhesion formation by suppressing p190A RhoGAP.

Authors:  Ashok K Pullikuth; Andrew D Catling
Journal:  Mol Cell Biol       Date:  2010-05-03       Impact factor: 4.272

8.  Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA.

Authors:  Isabel Molina-Ortiz; Rubén A Bartolomé; Pablo Hernández-Varas; Georgina P Colo; Joaquin Teixidó
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

9.  PKCdelta influences p190 phosphorylation and activity: events independent of PKCdelta-mediated regulation of endothelial cell stress fiber and focal adhesion formation and barrier function.

Authors:  Akua K Fordjour; Elizabeth O Harrington
Journal:  Biochim Biophys Acta       Date:  2009-07-23

10.  p190A RhoGAP is a glycogen synthase kinase-3-beta substrate required for polarized cell migration.

Authors:  Wei Jiang; Martha Betson; Roseann Mulloy; Rosemary Foster; Magdolna Lévay; Erzsébet Ligeti; Jeffrey Settleman
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.